Melanoma-Derived Exosomes Induce PD-1 Overexpression and Tumor Progression via Mesenchymal Stem Cell Oncogenic Reprogramming-Reference-Cited by-同舟云学术

Melanoma-Derived Exosomes Induce PD-1 Overexpression and Tumor Progression via Mesenchymal Stem Cell Oncogenic Reprogramming

Published:2019-10-18 Issue: Volume:10 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Gyukity-Sebestyén Edina,Harmati Mária,Dobra Gabriella,Németh István B.,Mihály Johanna,Zvara Ágnes,Hunyadi-Gulyás Éva,Katona Róbert,Nagy István,Horváth Péter,Bálind Árpád,Szkalisity Ábel,Kovács Mária,Pankotai Tibor,Borsos Barbara,Erdélyi Miklós,Szegletes Zsolt,Veréb Zoltán J.,Buzás Edit I.,Kemény Lajos,Bíró Tamás,Buzás Krisztina

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference55 articles.

1. Tumor microenvironment: the role of the tumor stroma in cancer;Li;J Cell Biochem,2007

2. The roles of tumor-derived exosomes in cancer pathogenesis;Yang;Clin Dev Immunol,2011

3. Exosomes as divine messengers: are they the Hermes of modern molecular oncology?;Braicu;Cell Death Differ,2015

4. Biological properties of extracellular vesicles and their physiological functions;Yáñez-Mó;J Extracell Vesicles,2015

5. Stressors alter intercellular communication and exosome profile of nasopharyngeal carcinoma cells;Harmati;J Oral Pathol Med,2017

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel insights into the regulation of exosomal PD-L1 in cancer: From generation to clinical application;European Journal of Pharmacology;2024-09

2. Multifaceted roles of PD‐1 in tumorigenesis: From immune checkpoint to tumor cell‐intrinsic function;Molecular Carcinogenesis;2024-05-15

3. Tumor Microenvironment Modulation by Cancer-Derived Extracellular Vesicles;Cells;2024-04-15

4. Tumorigenic and tumoricidal properties of exosomes in cancers; a forward look;Cell Communication and Signaling;2024-02-15

5. Current progress, strategy, and prospects of PD-1/PDL-1 immune checkpoint biosensing platforms for cancer diagnostics, therapy monitoring, and drug screening;Biosensors and Bioelectronics;2023-11